Recombinant MVA viruses expressing modified env, gag and pol genes from HIV clade A/G, clade B, and clade C Read more about Recombinant MVA viruses expressing modified env, gag and pol genes from HIV clade A/G, clade B, and clade C European Patent10014700.8Filed on 2005-08-29
Recombinant MVA Viruses Expressing Clade A/G, Clade B, and C Modified HIV Env, Gag, And Pol Genes Read more about Recombinant MVA Viruses Expressing Clade A/G, Clade B, and C Modified HIV Env, Gag, And Pol Genes Australia2012202786Filed on 2012-05-11
Influenza Hemagglutinin and Neuramindase Variants Read more about Influenza Hemagglutinin and Neuramindase Variants Japan2015-093758Filed on 2007-08-09
Vaccine Comprising AMA1 And RON2 Read more about Vaccine Comprising AMA1 And RON2 European Patent14742116.8Filed on 2014-07-01
Vaccine Comprising AMA1 and RON2 Read more about Vaccine Comprising AMA1 and RON2 US Patent 9,795,662Filed on 2015-12-30
Vaccine Compromising AMA1 and RON2 Read more about Vaccine Compromising AMA1 and RON2 India4229/KOLNP/2015Filed on 2014-07-01
Vaccine Comprising AMA1 And RON2 Read more about Vaccine Comprising AMA1 And RON2 China201480037643.1Filed on 2015-12-31
Cytolethal Distending Toxin Subunit B Conjugated or Fused to Bacillus Anthracis Toxin Lethal Factor Read more about Cytolethal Distending Toxin Subunit B Conjugated or Fused to Bacillus Anthracis Toxin Lethal Factor US Patent 9,890,369Filed on 2015-12-14
Novel Multivalent Nanoparticle-Based Vaccines Read more about Novel Multivalent Nanoparticle-Based Vaccines Patent Cooperation TreatyPCT/US2015/068272Filed on 2015-12-31